Key Takeaways
- • CME Group announced on April 7, 2026, that Avalanche (AVAX) and Sui (SUI) futures contracts will launch May 4, 2026, expanding its regulated crypto derivatives suite to eight digital assets.
- • AVAX futures will offer standard (5,000 AVAX) and micro (500 AVAX) contract sizes; SUI futures will feature standard (50,000 SUI) and micro (5,000 SUI) sizing, both cash-settled and cleared through CME Clearing.
- • CME crypto derivatives achieved $3 trillion in notional volume during 2025, with March average daily volume reaching nearly $8 billion and climbing 19% year-over-year.
- • CME's full cryptocurrency derivatives complex will transition to 24/7 trading on May 29, 2026, encompassing Bitcoin, Ether, Solana, XRP, Cardano, Chainlink, Stellar, and the newly added AVAX and SUI contracts.
- • Both AVAX and SUI futures will be priced off CME CF reference rates tied to New York settlement windows, providing institutional participants with regulated price discovery mechanisms.
Summary
CME Group announced Tuesday that it will launch regulated futures contracts for Avalanche (AVAX) and Sui (SUI) effective May 4, 2026. The announcement represents a continued expansion of CME's cryptocurrency derivatives offerings as the world's largest derivatives marketplace builds toward a comprehensive 24/7 trading environment for digital assets.
The new contracts expand CME's regulated crypto suite to eight digital assets, joining existing offerings in Bitcoin, Ether, Solana, XRP, Cardano, Chainlink, and Stellar. Each new asset will be offered in both standard and micro contract sizes to accommodate varying position sizes and capital requirements across the institutional investor base. AVAX futures will be sized at 5,000 AVAX for standard contracts and 500 AVAX for micro contracts, while SUI futures will carry standard sizing of 50,000 SUI and micro sizing of 5,000 SUI. Both products are cash-settled and will be cleared through CME Clearing, with pricing determined by CME CF reference rates tied to New York settlement windows.
CME's cryptocurrency derivatives business has demonstrated significant momentum, with 2025 notional volume reaching $3 trillion. March 2026 average daily volume climbed 19% year-over-year, with near-term average notional value traded reaching approximately $8 billion per day. Giovanni Vicioso, CME Group's global head of cryptocurrency products, emphasized that the new listings address institutional demand for enhanced flexibility and capital efficiency within a regulated trading environment. The broader strategic initiative will culminate in the May 29, 2026, transition of CME's entire crypto derivatives complex to 24/7 trading, pending regulatory review and approval from the CFTC.
The new contracts expand CME's regulated crypto suite to eight digital assets, joining existing offerings in Bitcoin, Ether, Solana, XRP, Cardano, Chainlink, and Stellar. Each new asset will be offered in both standard and micro contract sizes to accommodate varying position sizes and capital requirements across the institutional investor base. AVAX futures will be sized at 5,000 AVAX for standard contracts and 500 AVAX for micro contracts, while SUI futures will carry standard sizing of 50,000 SUI and micro sizing of 5,000 SUI. Both products are cash-settled and will be cleared through CME Clearing, with pricing determined by CME CF reference rates tied to New York settlement windows.
CME's cryptocurrency derivatives business has demonstrated significant momentum, with 2025 notional volume reaching $3 trillion. March 2026 average daily volume climbed 19% year-over-year, with near-term average notional value traded reaching approximately $8 billion per day. Giovanni Vicioso, CME Group's global head of cryptocurrency products, emphasized that the new listings address institutional demand for enhanced flexibility and capital efficiency within a regulated trading environment. The broader strategic initiative will culminate in the May 29, 2026, transition of CME's entire crypto derivatives complex to 24/7 trading, pending regulatory review and approval from the CFTC.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.